Ultima-Epithalon 10mg

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Epithalon Acetate

Pack: 1 vial (10 mg)

Epithalon is a synthetic form of the tetra-peptide known as Epithalamin (epithalon tetra), which occurs naturally in the brain's pineal gland. This tetra-peptide consists of four amino acids: alanine, glutamic acid, aspartic acid, and glycine. Research involving animals and humans has demonstrated a variety of positive biological effects. Prolonged exposure to Epithalamin has resulted in increased average and maximum life spans in aging rats, mice, and flies. In human cells, Epithalon promotes telomerase enzymatic activity and telomere extension, potentially through the reactivation of the telomerase gene. Telomerase serves to lengthen human DNA, effectively making cells biologically younger and creating the possibility of extending both a cell population's lifespan and that of the entire organism. A 12-month study involving patients with accelerated aging who were treated with Epithalon indicated that the peptide normalized metabolic functions and enhanced the state of various metabolic systems.

 

The peptide was also found to lower serum insulin and fatty acid levels in rabbits while enhancing glucose tolerance in these animals. Epithalon boosts the immune system by increasing the number of antibody-producing cells that combat infections. Additionally, it acts as a powerful antioxidant, promoting the production of several antioxidant enzymes within the body to enhance antioxidant defenses. Overall, findings indicate that epithalamin therapy is effective in reducing age-related diseases, including various cancers, metabolic disorders, and cardiovascular issues. These studies suggest that the peptide may have the ability to slow disease progression and extend human lifespan.

 

Epithalon should be administered subcutaneously or intramuscularly for optimal effectiveness, as it is broken down when taken orally. A dosage of 5 mg of Epithalon can be injected either once or twice daily, ideally in the morning and afternoon if opting for twice-daily dosing. It is recommended to inject Epithalon for 20 days at a time, followed by a break of four to six months between cycles. Once reconstituted in BAC water, Epithalon remains stable for a complete 20-day treatment cycle if stored at 4-8°C, after which it loses potency and should be disposed of.

 

Long-term clinical trials in humans have found no side effects associated with Epithalon. In these studies, the peptide was administered every three days at a dosage of 10 mg in 2 ml saline via intramuscular injection, with a six-month interval between treatment courses.